Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | 0.00% | 0.00% | 0.00% |
2023 | Motion for Asset Sale Approved for OncoSec Medical Incorporated | CI |
2023 | Motion for Asset Sale Filed by OncoSec Medical Incorporated | CI |
Financials (USD)
Sales 2021 | - | Sales 2022 | - | Capitalization | 28.35M |
---|---|---|---|---|---|
Net income 2021 | -45M | Net income 2022 | -34M | EV / Sales 2021 | - |
Net cash position 2021 | 33.63M | Net cash position 2022 | 1.12M | EV / Sales 2022 | - |
P/E ratio 2021 |
-1.59
x | P/E ratio 2022 |
-0.83
x | Employees | 41 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 84.57% |
6 months | -66.67% |
Managers | Title | Age | Since |
---|---|---|---|
David Canton
CTO | Chief Tech/Sci/R&D Officer | - | 13-12-31 |
Sandra Aung
PRN | Corporate Officer/Principal | - | 20-10-11 |
Bridget O'Keeffe
PRN | Corporate Officer/Principal | - | 21-02-17 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-12 | 0.0001 | 0.00% | 2,334 |
24-04-09 | 0.0001 | +9,900.00% | 1,782 |
Delayed Quote OTC Markets, April 12, 2024 at 03:23 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
0.00% | 596 | |
-1.78% | 41.71B | |
+47.70% | 41.56B | |
+4.01% | 39.74B | |
-15.14% | 25.61B | |
+3.16% | 24.26B | |
-24.08% | 18.55B | |
-2.67% | 11.93B | |
+24.76% | 11.93B | |
+7.01% | 10.91B |
- Stock Market
- Equities
- ONCSQ Stock